logo
logo

Subtle Medical Inc. raised over $30 million in a Series B+ round led by Samsung Ventures, bringing the total Series B funding to over $30 million.

Jul 24, 2024•12 months ago

Amount Raised

$30 Million

Round Type

series b

Menlo Park

Investors

Samsung VenturesIgnite InnovationBrv CapitalEnvision X CapitalFusion Fund

Description

Subtle Medical Inc. has raised close to $10 million in a Series B+ round, bringing the total Series B funding to over $30 million. The new funding will support further global expansion and new innovations for AI-powered medical imaging technology.

Company Information

Company

Subtle Medical

Location

Menlo Park, California, United States

About

Subtle Medical, Inc. is a healthcare technology company with deep learning solutions that improve workflow efficiency and patient experience. The company has the first AI software solutions FDA-cleared for medical imaging enhancement, SubtlePET™ and SubtleMR™. It was named CB Insights Top AI 100 and Digital Health 150 company in 2020 and is an Nvidia Inception Award Winner.  Current clinical partners include UCSF, Hoag Hospital, Mt. Sinai, Sickkids, Radnet, DASA, Tiantan Hospital, and Middlesex Hospital, among others. Subtle is currently in collaboration with top-tier medical device vendors, including Siemens Healthineers, GE Healthcare, Philips (China) and several pharmaceutical partners. Subtle was founded in 2017.  Seed investors include Bessemer Venture Partners, Zhenfund (Momentor Ventures), Data Collective, Breyer Capital, and Baidu Ventures, among others. For more information, please visit subtlemedical.com or email [email protected].

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech